Finance News – Drug Market
What is your interest today?
Bitcoin
Crypto
Btc
Ceo
Stocks
Investors
Tariffs
Shares
Stock
Crypto Assets
Stock Market
Cryptocurrency
Ethereum
Price
Markets
Xrp
Stablecoin
Investment
Blockchain
Bse
Etf
Ipo
Eth
Sec
Index
Solana
Trade
Inflation
Earnings
Coinbase
Interest Rates
Revenue
Token
Sensex
Wall Street
China
Nasdaq
Federal Reserve
Treasury
Traders
Nse
Gold
Bse Sensex
Sp 500
Economy
Nifty
Usd
Profit
Tesla
Digital Assets
Stock Buyback
Wbt
Exemption
British Carmakers
Short Term Rental
Token Distribution
Tax Plans
Us Vice President
St Jamess Place
Company Closures
= 1024) { setSearchBy('title'); suggestionOpen = true; fetch() }"
@input.debounce.300ms="window.innerWidth >= 1024 && fetch()"
@keydown.enter.prevent="window.innerWidth >= 1024 && submitSearch()"
placeholder="Search finance news…"
class="flex-grow bg-transparent border-0 focus:ring-0 px-4 py-2 placeholder-gray-500 dark:placeholder-gray-400 text-gray-900 dark:text-gray-100 mr-2"
/>
Filter by:
- ABC News Business
- BBC Business
- Business Insider Markets
- CBC Business
- City A.M.
- CNBC Business
- CoinDesk
- Cointelegraph
- Crypto News
- CryptoSlate
- Decrypt
- Economic Times Markets
- Euronews Business
- Financial Post Top Stories
- Financial Times
- Finextra Crypto
- Finextra Market
- Finextra Wealth
- Globe and Mail Investing
- Investing.com Global Markets
- Investing.com Global Mkts
- Investopedia
- Kiplinger
- MarketWatch MarketPulse
- MarketWatch Top Stories
- Quartz
- Sky News Money
- Sydney Morning Herald Biz
- Sydney Morning Herald Business
- TechCrunch Fintech
- The Block
- The Guardian – Business
- WSJ Markets News
MarketWatch Top Stories • Jun 25, 2025
After key conference, here’s how the race to a $150 billion weight-loss drug market is shaping up
Pharmaceutical firms are adjusting their strategies to compete in a rapidly growing weight-loss drug industry projected to reach substantial revenue, reflecting shifting opportunit...
Read Full Article →
Euronews Business • May 07, 2025
Novo Nordisk cuts guidance as weight-loss drug market competition grows
Novo Nordisk's quarterly results surpassed expectations, yet the company reduced its future growth projections due to increasing rivalry within the weight management pharmaceutical...
Read Full Article →